Skip to Content

Join the 'Spritam' group to help and get support from people like you.

Spritam News

Study Sheds Light on Safety of Driving With Epilepsy

Posted 5 Dec 2016 by Drugs.com

SUNDAY, Dec. 4, 2016 – People with epilepsy who experienced longer seizures during a simulated driving test may face an increased risk for crashes while on the road, a new study suggests. About 75 percent of people with epilepsy use medication to control their seizures and are able to drive. The remainder of patients typically keep a journal of seizures, noting how long they last, and doctors ...

Newer Epilepsy Drugs May Be Safer During Pregnancy

Posted 1 Sep 2016 by Drugs.com

THURSDAY, Sept. 1, 2016 – Women who take the new epilepsy drugs levetiracetam and topiramate during pregnancy don't run the risk of harming their infant's mental development, British researchers report. But the commonly prescribed anti-seizure drug valproate was linked with lower IQs in children, especially when taken at higher doses, researchers say. "The treatment of epilepsy in women who are ...

Personalized 'Pills' From a 3D Printer?

Posted 9 Nov 2015 by Drugs.com

MONDAY, Nov. 9, 2015 – With 3D printing, the concept of personalized medicine could take on a new dimension, researchers report. Mass-produced drugs can't take into account specific patient characteristics such as race, weight, and kidney and liver functions. Customized medications, on the other hand, might be more effective and less likely to cause side effects, the researchers said. For this ...

FDA Approves Spritam (levetiracetam) as the First 3D Printed Drug Product

Posted 4 Aug 2015 by Drugs.com

BLUE ASH, Ohio, August 3, 2015 – Aprecia Pharmaceuticals Company today announced that the U.S. Food and Drug Administration (FDA) has approved Spritam (levetiracetam) for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy.1 Spritam utilizes Aprecia's ...

FDA Approves First Pill Made by 3D Printing

Posted 4 Aug 2015 by Drugs.com

TUESDAY, Aug. 4, 2015 – The age of 3D printing has come to the drug industry, with the U.S. Food and Drug Administration on Monday approving the first pill made with the technology. The agency approved the prescription drug Spritam (levetiracetam) as a 3D-printed pill, to be taken with other medicines for seizures in certain children and adults with epilepsy. According to a news release from ...

Ask a Question

Further Information

Related Condition Support Groups

Seizures, Epilepsy

Spritam Patient Information at Drugs.com